Segments (Tables)

9 Months Ended

Sep. 30, 2018

Segments

Summary of results of operations by segment

	Dermatology		Contract		Corporate		Total
Three Months Ended September 30, 2018	Therapeutics		Research		and Other		Company
Revenue, net	$	510	$	3,225	$	(2,107)	$	1,628
Cost of revenue		126		2,823		(1,756)		1,193
Research and development		15,931		—		—		15,931
Sales and marketing		11,366		14		—		11,380
General and administrative		—		566		6,008		6,574
Loss from operations	$	(26,913)	$	(178)	$	(6,359)	$	(33,450)
	Dermatology		Contract		Corporate		Total
Three Months Ended September 30, 2017	Therapeutics		Research		and Other		Company
Revenue, net	$	—	$	1,212	$	(528)	$	684
Cost of revenue		—		893		(440)		453
Research and development		10,864		—		—		10,864
Sales and marketing		3,555		2		—		3,557
General and administrative		72		196		4,298		4,566
Loss from operations	$	(14,491)	$	121	$	(4,386)	$	(18,756)
	Dermatology		Contract		Corporate		Total
Nine Months Ended September 30, 2018	Therapeutics		Research		and Other		Company
Revenue, net	$	3,043	$	8,779	$	(5,400)	$	6,422
Cost of revenue		278		7,564		(4,501)		3,341
Research and development		43,472		—		—		43,472
Sales and marketing		34,996		34		—		35,030
General and administrative		—		1,557		19,398		20,955
Loss from operations	$	(75,703)	$	(376)	$	(20,297)	$	(96,376)
	Dermatology		Contract		Corporate		Total
Nine Months Ended September 30, 2017	Therapeutics		Research		and Other		Company
Revenue, net	$	—	$	1,212	$	(528)	$	684
Cost of revenue		—		893		(440)		453
Research and development		26,601		—		—		26,601
Sales and marketing		7,181		2		—		7,183
General and administrative		223		195		13,010		13,428
Loss from operations	$	(34,005)	$	122	$	(13,098)	$	(46,981)